Arkolith/Insider Trading/IDYA/Form 4

Ruiz Briseno Andres

See RemarksIDEAYA Biosciences, Inc. (IDYA) · full profile →Form 4 · filed Feb 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 28, 2025Grant(A)1K$16.91$21K26K
Nov 29, 2024Grant(A)682$23.26$16K25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 30, 2026Grant(A)80K—$080K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000032) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML